phrma logo

PhRMA

PhRMA Sites

Login

Explore Member-Only Resources

Access exclusive advocacy, policy, and research materials through the member site.

Login now

About

About

Our Agenda

Our Agenda

Policy Issues

We believe that patients should have access to innovative medicines.

Learn More

Innovation Ecosystem

Intellectual Property

Research & Development

Future of Medicine

Government Price Setting

International

Innovation Ecosystem

Patient Access & Affordability

PBMs & Middlemen

Hospitals and 340B

Insurance Coverage

Cost of Medicines

Medicare & Medicaid

Patient Access & Affordability

Resources

Our mission is to conduct effective advocacy for public policies that encourage the discovery of important, new medicines for patients by biopharmaceutical research companies.

Learn More

Resources

Resources

Newsroom

Newsroom

Blog

Blog

America's Medicines

PhRMA Foundation

PhRMA Foundation Logo

Voters for Cures

VotersForCures.org Logo

Working for Cures

workersforcures.org logo

This is Innovation

Innovation.org logo

View More

Search in PhRMA

Find resources, news, and articles related to policy issues and scientific innovation.

What are you looking for?

Most Recent

Policy Paper

Press

Blog

Report

Fact Sheet

Event

Resource

Pages

Leader

Author

Comment

not used title

not used title

Proposals to allow the importation of prescription medicines from Canada ignore the dangerous threat to patients of counterfeit and adulterated medicines. What actually happens when a patient orders a medicine through an online Canadian pharmacy may not be what you think. Counterfeit and adulterated medicines may contain paint, drywall or other harmful ingredients, be handled incorrectly or, in some cases, contain no active ingredients at all. Often these medicines look so similar patients cannot tell the difference. This infographic explores the realities of importation, comparing what you think happens in Canada with what actually happens.

Realities_Drug_Importation.jpg

Learn more at: PhRMA.org/Importation.

Allyson Funk

Ally is a former senior director of public affairs at PhRMA.

Allyson Funk

Author Twitter

Author LinkedIn

More oversight needed of unapproved medicines that threaten patients’ health

August 1, 2024

What they are saying: Florida Drug Importation Program is Unfeasible and Dangerous

January 17, 2024

Florida’s importation plan puts patients in danger

January 5, 2024

Three things to know about the accelerated approval pathway

December 12, 2022

What you don’t know about importation from Canada

Counterfeit Drugs

Prescription Drug Safety

Importation

What you don’t know about importation from Canada

February 17, 2017

What you don’t know about importation from Canada

Stay current on policy making

Sign up for email updates and follow us on social. 

About

Our Agenda

Policy Issues

Resources

Blog

Contact Us

Privacy Policy

Terms of Service

Facebook

Facebook

X

Twitter X

LinkedIn

LinkedIn

Instagram

instagram logo

America's Medicines

PhRMA Foundation

Voters for Cures

Working for Cures

Innovation.org

Please type your email

Success!

You've been added to the list